Fingolimod as a novel breast cancer therapy– overcoming its immunosuppressive effect by combination with the EGFR inhibitor gefitinib.

Funding or Partner Organisation: Ramsay Healthcare (Ramsay Healthcare Partner Funds)
Ramsay Healthcare (Ramsay Healthcare Partner Funds)

Start year: 2019

Acknowledgement of Country

UTS acknowledges the Gadigal people of the Eora Nation, the Boorooberongal people of the Dharug Nation, the Bidiagal people and the Gamaygal people, upon whose ancestral lands our university stands. We would also like to pay respect to the Elders both past and present, acknowledging them as the traditional custodians of knowledge for these lands.